Edition:
United Kingdom

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

11.02EUR
15 Dec 2017
Change (% chg)

€-0.03 (-0.27%)
Prev Close
€11.05
Open
€10.99
Day's High
€11.03
Day's Low
€10.85
Volume
113,281
Avg. Vol
219,877
52-wk High
€13.74
52-wk Low
€8.84

Latest Key Developments (Source: Significant Developments)

Fagron appoints ‍Rafael Padilla to succeed Hans Stols as CEO
Monday, 27 Nov 2017 

Nov 27 (Reuters) - FAGRON NV ::‍RAFAEL PADILLA SUCCEEDS HANS STOLS AS CEO​.‍MR. STOLS WILL RESIGN FROM ALL HIS FUNCTIONS AND MANDATES WITH IMMEDIATE EFFECT​.  Full Article

Fagron Q3 turnover ‍​up at 103.6 million euros
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - FAGRON NV ::Q3 TURNOVER EUR ‍​103.6 MILLION VERSUS EUR 103.4 MILLION YEAR AGO.BACKLOG IS EXPECTED TO BE LARGELY CLEARED IN THE Q1 OF 2018‍​.  Full Article

Fagron acquires All Chemistry in Brazil
Thursday, 5 Oct 2017 

Oct 5 (Reuters) - FAGRON NV ::FAGRON FURTHER EXECUTES BUY-AND-BUILD STRATEGY WITH ACQUISITION OF ALL CHEMISTRY IN BRAZIL.  Full Article

Fagron appoints Karin de Jong to board of directors
Monday, 17 Oct 2016 

Fagron NV : Karin de Jong joins the board of directors .Board of directors decided to co-opt Karin de Jong as executive director of Fagron.  Full Article

Fagron posts Q3 revenue of 103.4 mln euros, below Reuters poll
Wednesday, 12 Oct 2016 

Fagron NV : Fagron realises turnover of 103.4 million euros ($115.8 million), below 106 million euros seen in Reuters poll . Q3 revenue from continuing operations fell 1.1 percent to 103.4 million euros . Expected that the Wichita facility will have received all required licences and will have completed the validation processes early 2017 . Based on the current operations, Fagron expects to realise a turnover of at least 415 million euros and REBITDA of 85-95 million euros for the FY 2016 .Negative impact of changed reimbursement system on turnover, profitability of freedom pharmaceuticals in US to result in substantial goodwill write-off during the impairment test in Dec. 2016.  Full Article

Fagron: completion of the scrips private placement
Tuesday, 5 Jul 2016 

Fagron NV : Successful completion of the offering / completion of the scrips private placement . Announced that additional 5.38 pct of new shares have been committed to be subscribed to following completion of the private placement of the scrips .The new shares were offered at a ratio of 5 new shares for 16 preferential subscription rights at an issue price of 5.16 euro per new share.  Full Article

Fagron says 94.62 pct take up of rights offering
Tuesday, 5 Jul 2016 

Fagron NV : Says 94.62 pct take up of rights offering . Subscription price at 5.16 euros ($5.74) per new share . At the request of Fagron, the trading of the shares of Fagron on the regulated market of Euronext Brussels and Euronext Amsterdam will be temporarily suspended during the scrips private placement . Payment of issue price, completion of capital increase and delivery and listing of new shares to the markets of Euronext Brussels and Amsterdam is expected to take place on or around July 7, 2016 .New shares were offered at a ratio of 5 new shares for 16 preferential subscription rights.  Full Article

Fagron launches 88.2 million euro capital increase
Thursday, 16 Jun 2016 

Fagron NV : Capital increase with preferential subscription rights of maximum 88,265,360.40 euros ($99.54 million) through issuance of maximum 17,105,690 new shares at an issue price of 5.16 euros per share . Ratio: 5 new shares for 16 preferential subscription rights . Rights subscription period: June 17 until and including July 1 .Subscription commitments by WPEF VI Holdco III BE B.V., Alychlo NV, Carmignac Portfolio SICAV and Carmignac Gestion S.A., Midlin N.V. and Bart Versluys.  Full Article

Fagron settles capital increase with regard to Bellevue Pharmacy
Tuesday, 17 May 2016 

Fagron NV : Last condition precedent for capital increase with regard to Bellevue Pharmacy fulfilled .Fagron, Bellevue and interested parties reach and sign full and final settlement agreement.  Full Article

Fagron CFO Jan Peeters steps down
Tuesday, 10 May 2016 

Fagron NV : Jan Peeters steps down as CFO . Board of directors has unanimously decided to appoint Mrs. Karin de jong, employed by Fagron since May 2008, as CFO .Jan Peeters will remain available to hand over to his successor and will stay on as an advisor to the company until the end of this year.  Full Article

BRIEF-Fagron appoints ‍Rafael Padilla to succeed Hans Stols as CEO

* ‍MR. STOLS WILL RESIGN FROM ALL HIS FUNCTIONS AND MANDATES WITH IMMEDIATE EFFECT​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)